Skip to main content

Syndicate contentCornell

Diabetes surgery summit consensus lays foundation for new field of medicine

NEW YORK (Nov. 23, 2009) -- A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery.

New cancer target for non-Hodgkin's lymphoma

NEW YORK (Nov. 22 2009) -- Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells.

New map of variation in maize genetics holds promise for developing new varieties

ITHACA, N.Y. - A new study of maize has identified thousands of diverse genes in genetically inaccessible portions of the genome. New techniques may allow breeders and researchers to use this genetic variation to identify desirable traits and create new varieties that were not easily possible before.

Rice ties in race for atomic-scale breakthrough

Everybody loves a race to the wire, even when the result is a tie. The great irony is the ultraprecise clocks that could result from this competition could probably break any tie.

Small optical force can budge nanoscale objects

ITHACA, N.Y. - With a bit of leverage, Cornell researchers have used a very tiny beam of light with as little as 1 milliwatt of power to move a silicon structure up to 12 nanometers. That's enough to completely switch the optical properties of the structure from opaque to transparent.

Minimally invasive surgery shown safe and effective treatment for rectal cancer

Laparoscopic surgery has been used in the treatment of intestinal disorders for close to 20 years, but its benefits have only recently begun to be extended to people with rectal cancer.

Nitrogen loss threatens desert plant life, study shows

As the climate gets warmer, arid soils lose nitrogen as gas, reports a new Cornell study. That could lead to deserts with even less plant
life than they sustain today, say the researchers.

Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor

NEW YORK (November 5, 2009) -- Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical C

Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor

NEW YORK (November 5, 2009) -- Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical C

Researchers discover mechanism that prevents two species from reproducing

Cornell researchers have discovered a genetic mechanism in fruit flies that prevents two closely related species from reproducing, a finding that offers clues to how species evolve.

Emerging imaging modalities impact diagnosis of digestive disease

San Diego, CA (October 26, 2009) -- Recent advances in colonoscopic technology are featured in a number of studies presented at the Annual Scientific Meeting of the American College of Gastroenter

Emerging imaging modalities impact diagnosis of digestive disease

San Diego, CA (October 26, 2009) -- Recent advances in colonoscopic technology are featured in a number of studies presented at the Annual Scientific Meeting of the American College of Gastroenter

Study: Teachers' unions don't provide more pay

Teachers' unions have little impact on a school district's allocation of money, including teacher pay and spending per student, according to a study published this month in the Journal of Labor Economics.

New therapy for vasculitis will help patients avoid infertility and cancer

Researchers have identified that Rituxan, a drug previously approved for the treatment of non-Hodgkin's B cell lymphoma and rheumatoid arthritis, can treat severe ANCA-associated vasculitis as effectively as cyclophosphamide, the current standard therapy. The news will be presented October 18 at the annual meeting of the American College of Rheumatology in Philadelphia.

Drug could provide first treatment for scleroderma

Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive. The news will be presented at the annual meeting of the American College of Rheumatology on October 18 in Philadelphia.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes